SignatureFD’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-21,623
| Closed | -$97.7K | – | 3508 |
|
|
2025
Q4 | $97.7K | Sell |
21,623
-247
| -1% | -$1.26K | ﹤0.01% | 1334 |
|
|
2025
Q3 | $118K | Buy |
21,870
+45
| +0.2% | +$243 | ﹤0.01% | 1217 |
|
|
2025
Q2 | $119K | Sell |
21,825
-9,606
| -31% | -$38.1K | ﹤0.01% | 1165 |
|
|
2025
Q1 | $87.1K | Sell |
31,431
-4,709
| -13% | -$16.4K | ﹤0.01% | 1284 |
|
|
2024
Q4 | $123K | Buy |
36,140
+8,170
| +29% | +$23.6K | ﹤0.01% | 1129 |
|
|
2024
Q3 | $82.2K | Buy |
27,970
+5,927
| +27% | +$19.5K | ﹤0.01% | 1317 |
|
|
2024
Q2 | $74.9K | Buy |
22,043
+15,403
| +232% | +$50.4K | ﹤0.01% | 1305 |
|
|
2024
Q1 | $20.1K | Buy |
6,640
+4,622
| +229% | +$16.2K | ﹤0.01% | 1994 |
|
|
2023
Q4 | $8.5K | Sell |
2,018
-3,032
| -60% | -$16.4K | ﹤0.01% | 2328 |
|
|
2023
Q3 | $34.5K | Sell |
5,050
-288
| -5% | -$2.54K | ﹤0.01% | 1584 |
|
|
2023
Q2 | $55.6K | Buy |
5,338
+4,384
| +460% | +$39.2K | ﹤0.01% | 1362 |
|
|
2023
Q1 | $6.65K | Sell |
954
-251
| -21% | -$2.19K | ﹤0.01% | 2392 |
|
|
2022
Q4 | $7.27K | Buy |
1,205
+514
| +74% | +$3.8K | ﹤0.01% | 2284 |
|
|
2022
Q3 | $5K | Buy |
691
+47
| +7% | +$548 | ﹤0.01% | 2425 |
|
|
2022
Q2 | $9K | Sell |
644
-1,748
| -73% | -$28.9K | ﹤0.01% | 2153 |
|
|
2022
Q1 | $47K | Buy |
2,392
+1,659
| +226% | +$33.1K | ﹤0.01% | 1402 |
|
|
2021
Q4 | $25K | Buy |
733
+702
| +2,265% | +$28.2K | ﹤0.01% | 1692 |
|
|
2021
Q3 | $2K | Buy |
+31
| New | +$1.87K | ﹤0.01% | 2619 |
|
SignatureFD's CVAC Position: Q1 2026 in Review
SignatureFD sold out of CureVac (CVAC) in Q1 2026, closing a stake of 21,623 shares — an estimated $97.7K sold.
SignatureFD first reported a position in CVAC in Q3 2021 and held it in 18 quarters. The position peaked at $123K in Q4 2024. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- SignatureFD reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- SignatureFD sold 21,623 CureVac shares in Q1 2026, an estimated $97.7K.
- SignatureFD first reported a position in CureVac in Q3 2021 and held it in 18 quarters.
- SignatureFD's CureVac position peaked at $123K in Q4 2024.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.